Showing 6,061 - 6,080 results of 31,172 for search '(( 2 step decrease ) OR ( 50 ((((we decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 0.71s Refine Results
  1. 6061

    Twenty-two identified and replicated loci and their overlap with associations to metabolic traits and clinical phenotypes. by Johannes Raffler (793347)

    Published 2015
    “…We added their proxy variants in LD (r<sup>2</sup> ≥ 0.8; based on 1000 genomes project data [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005487#pgen.1005487.ref050" target="_blank">50</a>, <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005487#pgen.1005487.ref051" target="_blank">51</a>]). …”
  2. 6062

    Aged-Related Changes in Body Composition and Association between Body Composition with Bone Mass Density by Body Mass Index in Chinese Han Men over 50-year-old by Ying Jiang (5910)

    Published 2015
    “…</p><p>Conclusions</p><p>These data indicate that LMI and FFMI exhibited significant negative associations with aging in Chinese Han males older than 50 years, whereas FMI had a positive association. …”
  3. 6063

    Table2_Association of mean arterial pressure with non-alcoholic fatty liver disease: results from the NAGALA study.xlsx by Xinghui Li (434545)

    Published 2023
    “…Objective<p>Several recent reports have suggested the use of mean arterial blood pressure (MAP) to assess/predict the risk of developing atherosclerosis, chronic kidney disease, diabetes, metabolic syndrome, and poor prognosis in a variety of cardiovascular and cerebrovascular diseases. …”
  4. 6064

    Table1_Association of mean arterial pressure with non-alcoholic fatty liver disease: results from the NAGALA study.docx by Xinghui Li (434545)

    Published 2023
    “…Objective<p>Several recent reports have suggested the use of mean arterial blood pressure (MAP) to assess/predict the risk of developing atherosclerosis, chronic kidney disease, diabetes, metabolic syndrome, and poor prognosis in a variety of cardiovascular and cerebrovascular diseases. …”
  5. 6065
  6. 6066

    The fluorescence emission spectra of dihydropyrimidinase. by Cheng-Yang Huang (741252)

    Published 2015
    “…<p>The decrease in intrinsic fluorescence of protein was measured at 334.5 nm upon excitation at 279 nm and 25°C with a spectrofluorimeter. …”
  7. 6067

    Discovery of a Potent and Selective NF-κB-Inducing Kinase (NIK) Inhibitor That Has Anti-inflammatory Effects in Vitro and in Vivo by Zhiqiang Li (102723)

    Published 2020
    “…Treatment of such diseases with small-molecule NIK inhibitors is a reasonable but underexplored approach. In this paper, we reported the discovery of a potent and selective NIK inhibitor <b>46</b> (XT2). …”
  8. 6068
  9. 6069

    Modules of hormonal treatment studies. by Zahra Soltani (2898647)

    Published 2023
    “…As well as regulating SAR, <i>NPR1</i> has also been shown to be involved in the activation of ISR by the <i>SSI2</i>. <i>LOX2</i> catalyzes the first step of JA biosynthesis, <i>PKT3</i> plays an important role in wound-activated responses, and <i>OPR3</i> and <i>AOS</i> are involved in JA biosynthesis. …”
  10. 6070
  11. 6071
  12. 6072
  13. 6073
  14. 6074

    Silencing or suppression of TRPM7 inhibits cortical astrocyte proliferation. by Zhao Zeng (478844)

    Published 2015
    “…<p><b>A</b>. Representative images show the proliferation of astrocytes treated with control siRNA or TRPM7 siRNA. …”
  15. 6075
  16. 6076
  17. 6077
  18. 6078
  19. 6079
  20. 6080